Skip to content

Author

M. Keten

We have 5 of 38 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Predictors of Clinically Driven Target Lesion Revascularization After Endovascular Treatment of Femoropopliteal Chronic Total Occlusions

Background: Clinically driven target lesion revascularization (CD-TLR) following endovascular recanalization of femoropopliteal chronic total occlusions (CTOs) remains a primary determinant of long-term procedural durability. This study aimed to identify clinical, anatomical, and procedural predictors associated with 1...

Büşra Güvendi şengöR, B. Kültürsay, Mehmet Sengor et al. · 0 citations
Open access Oct 2026

Prognostic Value of the Non-HDL-C/HDL-C Ratio for Predicting One-Year Major Adverse Cardiac and Cerebrovascular Events in Young Patients with Myocardial Infarction.

OBJECTIVE Young patients with myocardial infarction (MI) remain at risk for recurrent cardiovascular events despite favorable short-term outcomes. The prognostic significance of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio in this population remains insuff...

M. Keten, Kadir Bıyıklı · 0 citations
Open access Aug 2026

Fibrosis-4 Index as an Independent Predictor of 1-Year Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction

Among patients with STEMI, the FIB-4 index was independently associated with adverse outcomes, and may add value to early risk assessment, although its incremental benefit over established risk models warrants further study.

M. Keten, Kadir Bıyıklı, B. Kültürsay et al. · 0 citations
Open access Jul 2026

Prognostic value of the Aggregate Index of Systemic Inflammation for 12-month major adverse cardiovascular events in patients with STEMI undergoing primary PCI

The Aggregate Index of Systemic Inflammation (AISI) is a novel composite biomarker reflecting overall inflammatory burden, however, its prognostic value in STEMI patients undergoing primary percutaneous coronary intervention (PCI) remains insufficiently explored.

Ismail Balaban, Seda Tanyeri Uzel, B. Kültürsay et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.